Article Abstract
Letter to the Editor
Reply to Agitation and Inpatient Suicide
Download Free PDF
This PDF is free for all visitors!
The Journal of Clinical Psychiatry
Letter to the Editor December 15, 2003
Reply to Agitation and Inpatient Suicide
J Clin Psychiatry 2003;64(12):1517-1518
Vol 87 • 2026 • Number 2
Read the Current Issue
Original Research
CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Original Research
Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease
Systematic Review
Thirty Years of the Diagnostic Criteria for Psychosomatic Research
Original Research
Efficacy of Olanzapine/Samidorphan on Negative Symptoms
Original Research
Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits
Clinical and Practical Psychopharmacology
Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes
Related Articles
Letter to the Editor
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
July 3, 2023
Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
